z-logo
open-access-imgOpen Access
Rationale, Design and Early Trial Performance of AOSpine North America Multi-Center Double Blind Randomized Controlled Trial of Safety and Efficacy of Riluzole in CSM (CSM – Protect Trial)
Author(s) -
Michael G. Fehlings,
Branko Kopjar
Publication year - 2016
Publication title -
global spine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.398
H-Index - 26
eISSN - 2192-5690
pISSN - 2192-5682
DOI - 10.1055/s-0036-1583080
Subject(s) - medicine , riluzole , randomized controlled trial , placebo , sample size determination , interim analysis , minimal clinically important difference , clinical trial , anesthesia , physical therapy , surgery , amyotrophic lateral sclerosis , disease , statistics , pathology , mathematics , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom